首页 > 市场调查报告书 > 医疗设备

生技设备 3D列印

市场调查报告书

商品编码

1390729

2023-2028 年按组件（3D 生物列印机、支架、生物材料）、应用（研究、临床）、最终用户（医院、研究组织和学术机构、生物製药公司）和地区分類的 3D 生物列印市场报告

3D Bioprinting Market Report by Component (3D Bioprinters, Scaffolds, Biomaterials), Application (Research, Clinical), End User (Hospitals, Research Organization and Academic Institutes, Biopharmaceuticals Companies), and Region 2023-2028

出版日期: 2023年11月24日 | 出版商:

IMARC | 英文 148 Pages | 商品交期: 2-3个工作天内

价格

简介目录图表

抽象的

2022年，全球3D生物列印市场规模达到10.32亿美元。展望未来， IMARC Group预计到2028年市场规模将达到26.21亿美元，2022-2028年复合年增长率（CAGR）为16.81%。不断增长的老年人口、对研发 (R&D) 活动的日益关注以及市场干扰的减少是推动市场发展的一些关键因素。

老年人口增加促进市场成长

目前，老年人口的成长是推动 3D 生物列印市场的主要因素之一。老年人群更容易患慢性病，因此对器官移植的需求增加。此外，各种医疗技术的广泛应用以及业内有能力的专家的存在正在支持市场的成长。

报告涵盖了市场结构、主要参与者的市场份额、参与者定位、最佳制胜策略、竞争仪表板和公司评估象限等竞争分析。此外，也提供了所有主要公司的详细资料。市场结构适度分散，该行业存在许多区域和全球参与者。由于资本投资高、进入和退出障碍过高，3D生物列印产业的新进入者数量适中。此外，由于几家製造商之间差异不大，因此行业内产品差异化程度适中。

什么是 3D 生物列印？

三维（3D）生物列印是一种专为开发精确解剖组织而设计的积层製造方法。它包括各种沉积和组装工艺，例如直接写入和雷射写入、微冲压、光刻、立体光刻、电子印刷和喷墨沉积。它依赖于使用活细胞、生物材料和活性生物分子製造的基于细胞的生物墨水的分解，以创建组织和器官的 3D 结构。它沉积多层生物材料来建造许多复杂的身体结构，如骨骼、皮肤、软骨、血管移植物、气管夹板和心臟组织。因此，3D生物列印在全球的医院、研究机构、学术机构和生物製药公司已被广泛应用。

COVID-19 影响：

COVID-19大流行的疫情为各行业带来了严重问题，也为许多国家带来了前所未有的挑战。但在 COVID-19 大流行期间，3D 生物列印已成为医疗保健产业的重要技术。由于医疗产品无法取得或短缺，对 3D 生物列印器官的需求增加。除此之外，多家公司正在使用最先进的 3D 生物列印平台来製造 SARS-CoV-2 感染的人类气道和肺部类器官模型。此外，这些模型也被用于研究 COVID-19 疾病进展和快速药物筛选。由于全球 COVID-19 病例不断增加，生物印表机的使用率增加。除此之外，由于生产过程的减少，疫情对3D生物列印市场造成了轻微的阻碍。由于病毒的广泛传播，在大流行的头几个月里，各个主要製造商被迫暂时关闭或暂停其生产过程。

3D生物列印市场趋势：

目前，消费者减少动物试验的意识不断增强，这是积极影响市场的主要因素之一。除此之外，老年族群更容易患各种慢性病，因此对 3D 生物列印的需求不断增长，这提供了积极的市场前景。此外，各种技术进步，例如器官晶片的发展，正在推动市场的成长。除此之外，世界各地大众对再生医学、癌症治疗和干细胞解决方案日益增长的需求也促进了市场的成长。此外，医疗保健行业中 3D 生物列印的采用率不断上升，因为这是一个受干扰较少的市场，正在支持市场的成长。此外，主要製造商正专注于研发（R＆D）活动，以引入生物列印组织，以降低新创新的成本并加快寻找新药的过程。

本报告回答的关键问题

2022年全球3D生物列印市场规模有多大？
2023-2028年全球3D生物列印市场的预期成长率是多少？
推动全球3D生物列印市场的关键因素是什么？
COVID-19 对全球 3D 生物列印市场有何影响？
基于组件的全球 3D 生物列印市场的细分情况如何？
基于应用的全球3D生物列印市场的细分情况如何？
基于最终用户的全球 3D 生物列印市场的细分情况如何？
全球3D生物列印市场的重点区域有哪些？
全球 3D 生物列印市场的主要参与者/公司有哪些？

3D生物列印机
- 市场走向
- 关键环节
  - 注射器/挤出生物列印
  - 喷墨生物列印
  - 磁浮生物列印
  - 雷射辅助生物列印
  - 其他的
- 市场预测
鹰架
- 市场走向
- 市场预测
生物材料
- 市场走向
- 关键环节
  - 活细胞
  - 水凝胶
  - 细胞外基质
  - 其他的
- 市场预测

第 7 章：按应用分類的市场区隔

研究
- 市场走向
- 关键环节
  - 药物研究
  - 再生医学
  - 3D 细胞培养
- 市场预测
临床
- 市场走向
- 关键环节
  - 皮肤
  - 骨骼和软骨
  - 血管
  - 其他的
- 市场预测

第 8 章：最终用户的市场区隔

医院
- 市场走向
- 市场预测
研究机构及学术机构
- 市场走向
- 市场预测
生物製药公司
- 市场走向
- 市场预测

第 9 章：按地区分類的市场区隔

北美洲
- 美国
  - 市场走向
  - 市场预测
- 加拿大
  - 市场走向
  - 市场预测
亚太
- 中国
  - 市场走向
  - 市场预测
- 日本
  - 市场走向
  - 市场预测
- 印度
  - 市场走向
  - 市场预测
- 韩国
  - 市场走向
  - 市场预测
- 澳洲
  - 市场走向
  - 市场预测
- 印尼
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
欧洲
- 德国
  - 市场走向
  - 市场预测
- 法国
  - 市场走向
  - 市场预测
- 英国
  - 市场走向
  - 市场预测
- 义大利
  - 市场走向
  - 市场预测
- 西班牙
  - 市场走向
  - 市场预测
- 俄罗斯
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
拉丁美洲
- 巴西
  - 市场走向
  - 市场预测
- 墨西哥
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
中东和非洲
- 市场走向
- 按国家/地区分類的市场细分
- 市场预测

第 10 章：SWOT 分析

概述
优势
弱点
机会
威胁

第 11 章：价值链分析

第 12 章：波特五力分析

概述
买家的议价能力
供应商的议价能力
竞争程度
新进入者的威胁
替代品的威胁

第 13 章：价格分析

第14章：竞争格局

市场结构
关键参与者
关键参与者简介
- 3D Systems Inc.
- Aspect Biosystems Ltd.
- Cellink
- Cyfuse Biomedical KK
- EnvisionTEC GmbH (Desktop Metal Inc.)
- GeSiM - Gesellschaft fur Silizium-Mikrosysteme mbH
- Materialise
- Organovo Holdings Inc.
- Poietis
- RegenHU
- Stratasys Ltd.

简介目录图表

Product Code: SR112023A4556

Abstract

The global 3D bioprinting market size reached US$ 1,032 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 2,621 Million by 2028, exhibiting a growth rate (CAGR) of 16.81% during 2022-2028. The growing geriatric population, increasing focus on research and development (R&D) activities, and less disrupted market represent some of the key factors driving the market.

Rising Geriatric Population Augmenting Market Growth

The rising geriatric population currently represents one of the primary factors driving the 3D bioprinting market. There is an increase in the demand for organ transplantation among the geriatric population, as they are more prone to chronic diseases. Moreover, the wide availability of various medical technologies and the presence of competent specialists in the industry is supporting the growth of the market.

Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. The market structure is moderately fragmented with the presence of numerous regional and global players in the industry. The volume of new entrants is moderate in the 3D bioprinting industry due to the high capital investments and excessive entry and exit barriers. Moreover, the product differentiation is moderate in the industry due to little differentiation between several manufacturers.

What is 3D Bioprinting?

Three-dimensional (3D) bioprinting refers to an additive manufacturing method designed for the development of precise anatomical tissues. It comprises various deposition and assembling processes, such as direct and laser writing, microstamping, photolithography, stereolithography, electro-printing, and inkjet deposition. It relies on the decomposition of cell-based bio-inks that are manufactured using living cells, biomaterials, and active biomolecules to create 3D structures of tissues and organs. It deposits multiple layers of biomaterials to build numerous complex bodily structures, such as bones, skin, cartilage, vascular grafts, tracheal splints, and heart tissues. As a result, 3D bioprinting is widely utilized in hospitals, research organizations, academic institutes, and biopharmaceutical companies across the globe.

COVID-19 Impact:

The COVID-19 pandemic outbreak caused severe problems for various industries and imposed unprecedented challenges on numerous countries. But 3D bioprinting has emerged as a vital technology in the healthcare industry during the COVID-19 pandemic. There was an increased demand for 3D bioprinted organs due to the unavailability or shortage of medical products. In addition to this, various companies were using state-of-the-art 3D bioprinting platforms to fabricate SARS-CoV-2-infected human airway and lung organoid models. Moreover, these models were being used to study COVID-19 disease progression and for rapid drug screening. There was an increased utilization of bioprinters on account of the rising COVID-19 cases across the globe. Apart from this, the pandemic has slightly hampered the 3D bioprinting market due to the reduction in the production process. Various key manufacturers were forced to temporarily shut down or pause their production process for the first few months of the pandemic due to the widespread of the virus.

3D Bioprinting Market Trends:

At present, the increasing awareness among consumers to minimize animal testing represents one of the major factors influencing the market positively. Besides this, the growing demand for 3D bioprinting among the geriatric population, as they are more prone to various chronic diseases, is offering a positive market outlook. In addition, various technological advancements, such as the development of organ-on-a-chip, is propelling the growth of the market. Apart from this, the increasing demand for regenerative medicines, cancer therapeutics, and stem cell solutions among the masses around the world is contributing to the growth of the market. Moreover, the rising adoption of 3D bioprinting in the healthcare industry, as it is a less disrupted market, is supporting the growth of the market. Furthermore, key manufacturers are focusing on research and development (R&D) activities to introduce bioprinted tissues to reduce the cost of new innovations and enhance the process of finding new drugs.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global 3D bioprinting market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on component, application and end user.

Component Insights:

3D Bioprinters

Syringe/Extrusion Bioprinting

Inkjet Bioprinting

Magnetic Levitation Bioprinting

Laser-assisted Bioprinting

Others

Scaffolds

Biomaterials

Living Cells

Hydrogels

Extracellular Matrices

Others

The report has provided a detailed breakup and analysis of the 3D bioprinting market based on the component. This includes 3D bioprinters (syringe or extrusion bioprinting, inkjet bioprinting, magnetic levitation bioprinting, laser-assisted bioprinting, and others), scaffolds, and biomaterials (living cells, hydrogels, extracellular matrices, and others). According to the report, 3D bioprinters (syringe or extrusion bioprinting, inkjet bioprinting, magnetic levitation bioprinting, laser-assisted bioprinting, and others) represented the largest segment due to the increasing utilization of syringe or extrusion-based bioprinting technology in printing various biological compounds or devices. In addition to this, the rising awareness among individuals about the 3D bioprinters technology is bolstering the growth of the market.

Application Insights:

Research

Drug Research

Regenerative Medicine

3D Cell Culture

Clinical

Skin

Bone and Cartilage

Blood Vessels

Others

A detailed breakup and analysis of the 3D bioprinting market based on the application has also been provided in the report. This includes research (drug research, regenerative medicine, and 3D cell culture) and clinical (skin, bone and cartilage, blood vessels, and others). According to the report, research (drug research, regenerative medicine, and 3D cell culture) accounted for the largest market share, as 3D printing technology is widely utilized among researchers to study the effects of different diseases and their progression and possible treatments. Moreover, it reduces the need to use lab animals for medical tests and dangerous trials on humans.

End User Insights:

Hospitals

Research Organization and Academic Institutes

Biopharmaceuticals Companies

A detailed breakup and analysis of the 3D bioprinting market based on the end user has also been provided in the report. This includes hospitals, research organization and academic institutes, and biopharmaceuticals companies. According to the report, biopharmaceuticals companies accounted for the largest market share due to the increasing number of target therapies. In addition, the rising collaborations and mergers among biopharmaceutical companies to develop 3D bioprinting is positively influencing the market.

Regional Insights:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for 3D bioprinting. Some of the factors driving the North America 3D bioprinting market included the growing prevalence of various chronic diseases, presence of key players, and increasing private and government investment. Moreover, the introduction of laser bio-printing method that can make live 3D printed bio-tissues to create artificial tissues is positively influencing the market.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global 3D bioprinting market. Some of the companies covered in the report include:

3D Systems Inc.

Aspect Biosystems Ltd.

Cellink

Cyfuse Biomedical K.K.

EnvisionTEC GmbH (Desktop Metal Inc.)

GeSiM - Gesellschaft fur Silizium-Mikrosysteme mbH

Materialise

Organovo Holdings Inc.

Poietis

RegenHU

Stratasys Ltd.

Please note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

1. What was the size of the global 3D bioprinting market in 2022?
2. What is the expected growth rate of the global 3D bioprinting market during 2023-2028?
3. What are the key factors driving the global 3D bioprinting market?
4. What has been the impact of COVID-19 on the global 3D bioprinting market?
5. What is the breakup of the global 3D bioprinting market based on the component?
6. What is the breakup of the global 3D bioprinting market based on the application?
7. What is the breakup of the global 3D bioprinting market based on the end user?
8. What are the key regions in the global 3D bioprinting market?
9. Who are the key players/companies in the global 3D bioprinting market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global 3D Bioprinting Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Component

6.1 3D Bioprinters
- 6.1.1 Market Trends
- 6.1.2 Key Segments
  - 6.1.2.1 Syringe/Extrusion Bioprinting
  - 6.1.2.2 Inkjet Bioprinting
  - 6.1.2.3 Magnetic Levitation Bioprinting
  - 6.1.2.4 Laser-assisted Bioprinting
  - 6.1.2.5 Others
- 6.1.3 Market Forecast
6.2 Scaffolds
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Biomaterials
- 6.3.1 Market Trends
- 6.3.2 Key Segments
  - 6.3.2.1 Living Cells
  - 6.3.2.2 Hydrogels
  - 6.3.2.3 Extracellular Matrices
  - 6.3.2.4 Others
- 6.3.3 Market Forecast

7 Market Breakup by Application

7.1 Research
- 7.1.1 Market Trends
- 7.1.2 Key Segments
  - 7.1.2.1 Drug Research
  - 7.1.2.2 Regenerative Medicine
  - 7.1.2.3 3D Cell Culture
- 7.1.3 Market Forecast
7.2 Clinical
- 7.2.1 Market Trends
- 7.2.2 Key Segments
  - 7.2.2.1 Skin
  - 7.2.2.2 Bone and Cartilage
  - 7.2.2.3 Blood Vessels
  - 7.2.2.4 Others
- 7.2.3 Market Forecast

8 Market Breakup by End User

8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Research Organization and Academic Institutes
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Biopharmaceuticals Companies
- 8.3.1 Market Trends
- 8.3.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 3D Systems Inc.
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
- 14.3.2 Aspect Biosystems Ltd.
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
- 14.3.3 Cellink
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
- 14.3.4 Cyfuse Biomedical K.K.
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
- 14.3.5 EnvisionTEC GmbH (Desktop Metal Inc.)
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
- 14.3.6 GeSiM - Gesellschaft fur Silizium-Mikrosysteme mbH
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
- 14.3.7 Materialise
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
  - 14.3.7.3 Financials
- 14.3.8 Organovo Holdings Inc.
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
  - 14.3.8.3 Financials
- 14.3.9 Poietis
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio
- 14.3.10 RegenHU
  - 14.3.10.1 Company Overview
  - 14.3.10.2 Product Portfolio
- 14.3.11 Stratasys Ltd.
  - 14.3.11.1 Company Overview
  - 14.3.11.2 Product Portfolio
  - 14.3.11.3 Financials

简介目录图表

List of Figures

Figure 1: Global: 3D Bioprinting Market: Major Drivers and Challenges
Figure 2: Global: 3D Bioprinting Market: Sales Value (in Million US$), 2017-2022
Figure 3: Global: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 4: Global: 3D Bioprinting Market: Breakup by Component (in %), 2022
Figure 5: Global: 3D Bioprinting Market: Breakup by Application (in %), 2022
Figure 6: Global: 3D Bioprinting Market: Breakup by End User (in %), 2022
Figure 7: Global: 3D Bioprinting Market: Breakup by Region (in %), 2022
Figure 8: Global: 3D Bioprinting (3D Bioprinters) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: 3D Bioprinting (3D Bioprinters) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: 3D Bioprinting (Scaffolds) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: 3D Bioprinting (Scaffolds) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: 3D Bioprinting (Biomaterials) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: 3D Bioprinting (Biomaterials) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: 3D Bioprinting (Research) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: 3D Bioprinting (Research) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: 3D Bioprinting (Clinical) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: 3D Bioprinting (Clinical) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: 3D Bioprinting (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: 3D Bioprinting (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: 3D Bioprinting (Research Organization and Academic Institutes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: 3D Bioprinting (Research Organization and Academic Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: 3D Bioprinting (Biopharmaceuticals Companies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: 3D Bioprinting (Biopharmaceuticals Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: North America: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: North America: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: United States: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: United States: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Canada: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Canada: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Asia-Pacific: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Asia-Pacific: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: China: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: China: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Japan: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Japan: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: India: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: India: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: South Korea: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: South Korea: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: Australia: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: Australia: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Indonesia: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Indonesia: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Others: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Others: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Europe: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Europe: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Germany: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Germany: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: France: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: France: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: United Kingdom: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: United Kingdom: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Italy: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Italy: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Spain: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Spain: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Russia: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Russia: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Others: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Others: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Latin America: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Latin America: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Brazil: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Brazil: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Mexico: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Mexico: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Others: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Others: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Middle East and Africa: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Middle East and Africa: 3D Bioprinting Market: Breakup by Country (in %), 2022
Figure 72: Middle East and Africa: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Global: 3D Bioprinting Industry: SWOT Analysis
Figure 74: Global: 3D Bioprinting Industry: Value Chain Analysis
Figure 75: Global: 3D Bioprinting Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: 3D Bioprinting Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: 3D Bioprinting Market Forecast: Breakup by Component (in Million US$), 2023-2028
Table 3: Global: 3D Bioprinting Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 4: Global: 3D Bioprinting Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 5: Global: 3D Bioprinting Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: 3D Bioprinting Market: Competitive Structure
Table 7: Global: 3D Bioprinting Market: Key Players

02-2729-4219

+886-2-2729-4219